RxDoctor Payments Data

Ali Ahmed, MD

Gastroenterology · Birmingham, ALNPI 1649431511

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 73.6% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $13,245 and has fallen 60.0% since, to $5,299 in 2025. Among gastroenterology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,161in general payments, 2019–2025

Across 139 payments — averaging $195.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$20K
  • Gyrus ACMI, Inc.$2K
  • Pentax Of America, Inc.$2K
  • Olympus Corporation$970
  • Apollo Endosurgery US Inc$847
  • Medtronic$414
  • plus $945 from 10 others

What the payments were for

  • Consulting fees$4,42516%
  • Speaking & faculty fees$15,92059%
  • Travel & lodging$2,3028%
  • Food & beverage$4,51417%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,161 in reported general payments places this provider in the 90th percentile of 225 gastroenterology providers in Alabama.

See all gastroenterology providers in Alabama

Medicare billing

Part B allowed, 2024
$38,369
Medicare patients
90
Services billed
254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl24$333

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →